Cipher Patent-Cliff Exposure & CMS Drug Spending Portfolio

Cipher (US): 3 reconciled FDA prescription therapies, $52.9M 2024 CMS Part D & Medicaid spend, and 2 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Headquarters / ClusterUS
Reconciled FDA Portfolio Therapies3
2025 to 2030 Patent-Cliff Revenue Exposure0.0%
Primary Portfolio LOE Date2033-01-01
2024 CMS Total Public Spend$52.9M
2024 Medicare Part D Spend$370K
2024 Medicaid Spend$52.6M
California HCAI SB 17 Filings2 WAC filings (max 19.8% 2-yr change)